VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AstraZeneca PLC vs L3Harris Technologies, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisL3Harris Technologies, Inc.
LHX · NYSE
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into L3Harris Technologies, Inc.'s moat claims, evidence, and risks.
View LHX analysisComparison highlights
- Moat score gap: L3Harris Technologies, Inc. leads (72 / 100 vs 71 / 100 for AstraZeneca PLC).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); L3Harris Technologies, Inc. has 4 segments (31.9% in Space & Airborne Systems).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; L3Harris Technologies, Inc. has 8 across 3.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
L3Harris Technologies, Inc.
Space & Airborne Systems
Defense & intelligence space and airborne mission systems (payloads, sensors, avionics, mission networks)
Global (U.S.-centric demand)
Government defense/intelligence agencies, prime contractors, and allied governments
Prime contractor / subsystem integrator
31.9%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
L3Harris Technologies, Inc. strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
L3Harris Technologies, Inc. segments
Full profile >Space & Airborne Systems
Oligopoly
Integrated Mission Systems
Oligopoly
Communication Systems
Oligopoly
Aerojet Rocketdyne
Duopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.